Skip to main content

Press releases

The company FluxPharm has acquired a licence for a chemical process developed at the Max Planck Institute of Colloids and Interfaces in Potsdam. Using...

Daiichi Sankyo, Max Planck Innovation GmbH and the Lead Discovery Center GmbH have signed an agreement providing Daiichi Sankyo with the option to...

 

The Munich-based medical technology company terraplasma medical GmbH successfully completed the first round of major financing (seed). The raised...

Cardior Pharmaceuticals today announced the completion of a €15 million series A financing round. Cardior is pioneering its proprietary RNA technology...

Max Planck Innovation signs agreement with Lula Robotics to develop technology for autonomous robotics

On 22 and 23 May, Max Planck Innovation will present a therapy for sustainable growth of new hair and a new approach for the non-invasive detection...

The start-up company PreOmics licenses several technologies of the Max Planck Institute of Biochemistry in Martinsried for the preparation of samples...

“Inhale deeply ... and exhale.” This is what a test for lung cancer could be like in future. Scientists at the Max Planck Institute for Heart and...

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Repairon...


Contact | Main Office

TransferAllianz e. V.
Christiane Bach-Kaienburg
(Managing Director)

c/o PROvendis GmbH
Schloßstr. 11-15
D-45468 Mülheim an der Ruhr